Sintetica S.A.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Feb 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Oct 30, 2027The maintenance fee for Topical Formulations of Chloroprocaine and Methods of Using Same (US 11,969,403) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,263,660 | Stable hyperbaric composition comprising prilocaine HCl, use of said new composition for intrathecal anaethesia, and method for manufacturing said composition In force · From the USPTO record | In force | From the USPTO record | |
| US 8,969,412 | Use for a Composition Comprising Chloroprocaine HCL, a New Composition Comprising Chloroprocaine HCL and a Method for Its Manufacture In force · High confidence | In force | High confidence | |
| US 9,504,666 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration In force · From the USPTO record | In force | From the USPTO record | |
| US RE49,422 | Process for producing a stable low concentration, injectable solution of noradrenaline In force · Low confidence | In force | Low confidence | |
| US RE49,443 | Process for producing a stable low concentration, injectable solution of noradrenaline In force · Low confidence | In force | Low confidence | |
| US RE49,555 | Process for producing a stable low concentration, injectable solution of noradrenaline In force · Low confidence | In force | Low confidence | |
| US 10,792,271 | Topical Formulations of Chloroprocaine and Methods of Using Same In force · High confidence | In force | High confidence | |
| US 11,969,403 | Topical Formulations of Chloroprocaine and Methods of Using Same In force · High confidence | In force | High confidence | |
| US 11,590,105 | Intrathecal Administration of Levetiracetam In force · High confidence | In force | High confidence | |
| US 12,564,561 | Dilute Ready to Use Large Volume Containers of Phenylephrine In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 3 lapsed for an unpaid fee · 12 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 3 abandoned · 2 no status recorded